Mastercard Incorporated (MA) capitalization

Current snapshot

Market Cap
$446.20B
893.0M shares × $499.66 · as of last filing 2026-03-31
Net Worth
$6.72B
Stockholders' equity · 2026-03-31
Enterprise Value
$457.25B
Market cap + debt − cash
Net Debt
$11.05B
Debt $18.96B − Cash $7.91B

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $517.22B
FY'24 2024-12-31 $488.13B
FY'23 2023-12-31 $403.48B
FY'22 2022-12-31 $337.65B
FY'21 2021-12-31 $356.45B
FY'20 2020-12-31 $359.08B
FY'19 2019-12-31 $305.16B
FY'19 2018-12-31 $197.52B
FY'19 2017-12-31 $162.26B
FY'16 2016-12-31 $113.68B
FY'16 2015-12-31 $110.70B
FY'14 2014-12-31 $100.72B
FY'11 2013-12-31 $101.51B
FY'12 2012-12-31 $61.80B
FY'11 2011-12-31 $47.87B
FY'10 2010-12-31 $29.36B
FY'09 2009-12-31 $33.28B
FY'09 2008-12-31 $18.58B
FY'09 2007-12-31 $29.08B

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $446.20B
Q4'25 2025-12-31 $517.22B
Q3'25 2025-09-30 $514.77B
Q2'25 2025-06-30 $510.80B
Q1'25 2025-03-31 $500.98B
Q4'24 2024-12-31 $488.13B
Q3'24 2024-09-30 $456.76B
Q2'24 2024-06-30 $410.28B
Q1'24 2024-03-31 $450.27B
Q4'23 2023-12-31 $403.48B
Q3'23 2023-09-30 $373.34B
Q2'23 2023-06-30 $373.24B
Q1'23 2023-03-31 $347.42B
Q4'22 2022-12-31 $337.65B
Q3'22 2022-09-30 $275.24B
Q2'22 2022-06-30 $307.28B
Q1'22 2022-03-31 $350.59B
Q4'21 2021-12-31 $356.45B
Q3'21 2021-09-30 $344.20B
Q2'21 2021-06-30 $362.90B
Q1'21 2021-03-31 $355.34B
Q4'20 2020-12-31 $359.08B
Q3'20 2020-09-30 $339.86B
Q2'20 2020-06-30 $298.07B
Q1'20 2020-03-31 $243.98B
Q4'19 2019-12-31 $302.47B
Q3'19 2019-09-30 $276.73B
Q2'19 2019-06-30 $271.14B
Q1'19 2019-03-31 $242.98B
Q4'19 2018-12-31 $195.82B
Q3'18 2018-09-30 $232.18B
Q2'18 2018-06-30 $206.15B
Q1'18 2018-03-31 $185.14B
Q1'18 2018-01-01
Q4'19 2017-12-31 $162.26B
Q3'17 2017-09-30 $150.80B
Q2'17 2017-06-30 $130.56B
Q2'17 2017-04-28
Q1'17 2017-03-31 $121.69B
Q4'16 2016-12-31 $112.54B
Q3'16 2016-09-30 $111.85B
Q2'16 2016-06-30 $96.95B
Q1'16 2016-03-31 $105.08B
Q4'16 2015-12-31 $109.43B
Q3'15 2015-09-30 $102.11B
Q2'15 2015-06-30 $106.66B
Q1'15 2015-03-31 $99.52B
Q4'14 2014-12-31 $99.69B
Q3'14 2014-09-30 $85.75B
Q2'14 2014-06-30 $85.89B
Q1'14 2014-03-31 $88.82B
Q4'11 2013-12-31 $100.67B
Q3'13 2013-09-30 $81.34B
Q2'13 2013-06-30 $69.92B
Q1'13 2013-03-31 $66.56B
Q4'12 2012-12-31 $61.21B
Q3'12 2012-09-30 $56.48B
Q2'12 2012-06-30 $54.32B
Q1'12 2012-03-31 $53.45B
Q4'11 2011-12-31 $47.35B
Q3'11 2011-09-30 $40.28B
Q2'11 2011-06-30 $38.57B
Q1'11 2011-03-31 $32.98B
Q4'10 2010-12-31 $29.36B
Q3'10 2010-09-30 $29.34B
Q2'10 2010-06-30 $26.14B
Q1'10 2010-03-31 $33.27B
Q4'09 2009-12-31 $28.27B
Q3'09 2009-09-30 $26.28B
Q2'09 2009-06-30 $21.75B
Q1'10 2009-03-31 $21.77B
Q4'09 2008-12-31 $18.58B
Q3'09 2008-09-30 $22.97B
Q2'09 2008-06-30 $34.54B

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (MA CIK 0001141391), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

REGN

REGENERON PHARMACEUTICALS, INC.

ATLC

Atlanticus Holdings Corp

HHS

HARTE HANKS, INC.